Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126039201 | 12603920 | 1 | I | 20070222 | 20160721 | 20160728 | 20160728 | EXP | CA-JNJFOC-20160718081 | JANSSEN | 65.09 | YR | A | M | Y | 127.01000 | KG | 20160728 | CN | CA | CA |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126039201 | 12603920 | 1 | PS | STELARA | USTEKINUMAB | 1 | Subcutaneous | U | U | UNKNOWN | 125261 | 45 | MG | SOLUTION FOR INJECTION |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126039201 | 12603920 | 1 | Psoriasis |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126039201 | 12603920 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126039201 | 12603920 | Lower respiratory tract infection | |
126039201 | 12603920 | Nasopharyngitis | |
126039201 | 12603920 | Off label use | |
126039201 | 12603920 | Product use issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126039201 | 12603920 | 1 | 20070222 | 0 |